What is ChromoLogic?
ChromoLogic LLC operates as a dedicated innovation hub, concentrating on the creation of advanced biomedical and industrial technologies. Its biomedical division is committed to enhancing healthcare through solutions in wound care, diagnostics, drug delivery, and telehealth, aiming to directly improve patient outcomes and save lives. Concurrently, the industrial arm of ChromoLogic addresses critical needs in supply chain traceability and security, offering robust systems for asset management. The company's dual focus allows it to serve a broad spectrum of clients, including healthcare providers and various industries that require secure and reliable operational frameworks. ChromoLogic's mission is deeply rooted in sustainability and community engagement, driving its pursuit of impactful technologies that tackle significant societal challenges.
How much funding has ChromoLogic raised?
ChromoLogic has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$756K
Debt (2020): $350K with participation from PPP
Debt (2021): $756K led by PPP
What's next for ChromoLogic?
With the recent infusion of $756K in strategic capital, ChromoLogic is poised for accelerated growth and the expansion of its innovative product lines. The enterprise-level funding context suggests a strategic phase focused on scaling production, enhancing market penetration, and potentially exploring new research and development avenues. This backing will likely enable ChromoLogic to solidify its position in both the biomedical and industrial sectors, further developing its solutions for wound care, diagnostics, drug delivery, telehealth, and supply chain security. The company's commitment to addressing underserved societal needs through technology positions it for sustained impact and future investment opportunities.
See full ChromoLogic company page
